Canada Neuralgia Treatment Market Size & Outlook, 2020-2027
Canada neuralgia treatment market, 2016-2027 (US$M)
Related Markets
Canada neuralgia treatment market highlights
- The Canada neuralgia treatment market generated a revenue of USD 76.5 million in 2020 and is expected to reach USD 118.0 million by 2027.
- The Canada market is expected to grow at a CAGR of 6.4% from 2021 to 2027.
- In terms of segment, surgery was the largest revenue generating treatment in 2020.
- Drug Based is the most lucrative treatment segment registering the fastest growth during the forecast period.
Neuralgia treatment market data book summary
| Market revenue in 2020 | USD 76.5 million |
| Market revenue in 2027 | USD 118.0 million |
| Growth rate | 6.4% (CAGR from 2020 to 2027) |
| Largest segment | Surgery |
| Fastest growing segment | Drug Based |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Based, Surgery |
| Key market players worldwide | GlaxoSmithKline Consumer Healthcare (GSK CH India), GlaxoSmithKline, Pfizer Inc, Novartis AG ADR, Biogen Inc, H. Lundbeck AS Class A, Cadila Pharmaceuticals |
Other key industry trends
- In terms of revenue, Canada accounted for 4.1% of the global neuralgia treatment market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In North America, U.S. neuralgia treatment market is projected to lead the regional market in terms of revenue in 2027.
- Canada is the fastest growing regional market in North America and is projected to reach USD 118.0 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neuralgia Treatment Market Scope
Neuralgia Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada neuralgia treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neuralgia treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 65.49% in 2020. Horizon Databook has segmented the Canada neuralgia treatment market based on drug based, surgery covering the revenue growth of each sub-segment from 2016 to 2027.
- Canada Neuralgia Treatment Treatment Outlook (Revenue, USD Million, 2016-2027)
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Canada Neuralgia Treatment End Use Outlook (Revenue, USD Million, 2016-2027)
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
Reasons to subscribe to Canada neuralgia treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada neuralgia treatment market databook
-
Our clientele includes a mix of neuralgia treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada neuralgia treatment market, including forecasts for subscribers. This country databook contains high-level insights into Canada neuralgia treatment market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Canada neuralgia treatment market size, by treatment, 2016-2027 (US$M)
Canada Neuralgia Treatment Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
